21.05.2015 • News

DSM and Ascend in global PA 6.6 Compounds Alliance

Dutch chemical producer DSM and US-based Ascend Performance Materials, the former Solutia polyamide business currently owned by private equity investor SK Capital, have formed a global strategic alliance for compounds based on PA 6.6.

Ascend will become the strategic supplier to DSM for base polymer used to produce its Akulon PA 6.6 compounds for engineering plastics applications. At the same time, the Heerlen-based company will globally distribute Ascend's portfolio of PA 6.6 compounds sold under the brand name Vydyne.

DSM is already a major developer and global supplier of polyamide engineering plastics with a portfolio including in addition to PA 6.6 several other high performance polyamides such as its Stanyl brand PA 46, its Stanyl ForTii and EcoPaXX, a bio-based PA claimed to be completely carbon neutral.

In addition, DSM manufactures thermoplastic polyesters PBT and PET (Arnite) as well as TPE (Arnitel) for engineering applications.

One of the largest producers of PA6.6 resin worldwide, Ascend is fully back-integrated into the key chemical intermediates adiponitrile, hexamethylene diamine, and adipic acid.

Through its Vydyne PA66 resin and compounds, the US company said it is focused on growth in engineered plastics applications. The agreement with DSM will give it "significantly greater access to global customers."

At Pensacola, Florida, on the US Gulf Coast, Ascend operates what it claims is the largest integrated site for PA 6.6 worldwide. Also in the US, the company recently added a state-of-the-art 30,000 t/y compounding plant at Greenwood, South Carolina.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.